These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11926892)

  • 1. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.
    Psaty BM; Smith NL; Heckbert SR; Vos HL; Lemaitre RN; Reiner AP; Siscovick DS; Bis J; Lumley T; Longstreth WT; Rosendaal FR
    JAMA; 2002 Apr; 287(13):1680-9. PubMed ID: 11926892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction.
    van Wieren-de Wijer DB; Maitland-van der Zee AH; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; Psaty BM; van Duijn CM; Stricker BH; Klungel OH
    J Hypertens; 2009 Jan; 27(1):61-8. PubMed ID: 19145769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
    Gerhard T; Gong Y; Beitelshees AL; Mao X; Lobmeyer MT; Cooper-DeHoff RM; Langaee TY; Schork NJ; Shriver MD; Pepine CJ; Johnson JA;
    Am Heart J; 2008 Aug; 156(2):397-404. PubMed ID: 18657677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
    Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
    JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.
    Bis JC; Smith NL; Psaty BM; Heckbert SR; Edwards KL; Lemaitre RN; Lumley T; Rosendaal FR
    Am J Hypertens; 2003 Dec; 16(12):1011-7. PubMed ID: 14643574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-adducin Gly460Trp variant increases the risk of stroke in hypertensive Dutch women.
    Zafarmand MH; van der Schouw YT; Grobbee DE; de Leeuw PW; Bots ML
    Hypertension; 2008 Jun; 51(6):1665-70. PubMed ID: 18458162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension.
    Gupta S; Jhawat V; Agarwal BK; Roy P; Saini V
    Curr Hypertens Rev; 2019; 15(2):123-134. PubMed ID: 30062972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population.
    Castellano M; Barlassina C; Muiesan ML; Beschi M; Cinelli A; Rossi F; Rizzoni D; Cusi D; Agabiti-Rosei E
    J Hypertens; 1997 Dec; 15(12 Pt 2):1707-10. PubMed ID: 9488226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic-gene interaction and the risk of myocardial infarction and stroke.
    Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Pharmacogenomics J; 2007 Oct; 7(5):346-52. PubMed ID: 17189961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.
    Glorioso N; Manunta P; Filigheddu F; Troffa C; Stella P; Barlassina C; Lombardi C; Soro A; Dettori F; Parpaglia PP; Alibrandi MT; Cusi D; Bianchi G
    Hypertension; 1999 Oct; 34(4 Pt 1):649-54. PubMed ID: 10523341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study.
    Davis BR; Arnett DK; Boerwinkle E; Ford CE; Leiendecker-Foster C; Miller MB; Black H; Eckfeldt JH
    Pharmacogenomics J; 2007 Apr; 7(2):112-22. PubMed ID: 16702981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
    Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy.
    Sciarrone MT; Stella P; Barlassina C; Manunta P; Lanzani C; Bianchi G; Cusi D
    Hypertension; 2003 Mar; 41(3):398-403. PubMed ID: 12623934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular risk.
    van Rijn MJ; Bos MJ; Yazdanpanah M; Isaacs A; Arias-Vásquez A; Koudstaal PJ; Hofman A; Witteman JC; van Duijn CM; Breteler MM
    Stroke; 2006 Dec; 37(12):2930-4. PubMed ID: 17082469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis.
    Meckley LM; Veenstra DL
    Pharmacogenet Genomics; 2006 Feb; 16(2):139-47. PubMed ID: 16424826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of myocardial infarction associated with antihypertensive drug therapies.
    Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
    JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population.
    Wang JG; Staessen JA; Barlassina C; Fagard R; Kuznetsova T; Struijker-Boudier HA; Zagato L; Citterio L; Messaggio E; Bianchi G
    Kidney Int; 2002 Dec; 62(6):2152-9. PubMed ID: 12427140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.